Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis
Condition: Juvenile Spondyloarthritis · Sponsor: Children's Hospital of Philadelphia
About this study
This randomized pragmatic trial will generate knowledge about strategies used to de-escalate tumor necrosis factor inhibitor (TNFi) therapy in patients with juvenile spondyloarthritis with sustained inactive disease and are treated at one of the 31 participating pediatric healthcare systems. This open label study will be conducted in the setting of routine clinical care and will compare the risk and timing of flare (Aim 1) and patients' lived experiences (Aim 2) across three arms.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (31)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Phoenix Children's | Phoenix, Arizona, United States | — |
| Children's Hospital Los Angeles | Los Angeles, California, United States | — |
| Stanford University | Palo Alto, California, United States | — |
| Children's Hospital of Colorado | Aurora, Colorado, United States | — |
| Nemours Children's Hospital | Wilmington, Delaware, United States | — |
| Children's National Health System | Washington D.C., District of Columbia, United States | — |
| Nemours Children's Health | Orlando, Florida, United States | — |
| Children's Healthcare of Atlanta | Atlanta, Georgia, United States | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | — |
| Riley Hospital for Children at IU Health | Indianapolis, Indiana, United States | — |
| University of Iowa Stead Family Children's Hospital | Iowa City, Iowa, United States | — |
+ 19 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04891640